Compare commits
10 commits
2c06453493
...
45ef05935f
| Author | SHA1 | Date | |
|---|---|---|---|
|
|
45ef05935f | ||
|
|
ac469f9bf3 | ||
|
|
1c237ee5f9 | ||
|
|
dbea7635c7 | ||
|
|
614e7dba68 | ||
|
|
d37fcbbebe | ||
|
|
e802d06225 | ||
|
|
71c19b860c | ||
|
|
f0f55e98f4 | ||
|
|
9e6d030aa2 |
37 changed files with 328 additions and 88 deletions
|
|
@ -52,3 +52,17 @@ EU AI Act Omnibus trilogue demonstrates Mode 5 variant: both Council and Parliam
|
|||
**Source:** Acemoglu, Project Syndicate March 2026
|
||||
|
||||
Acemoglu provides cross-disciplinary confirmation from institutional economics that Mode 6 (emergency exception override) shares the same governance philosophy as Mode 5: emergency exceptionalism where constraints are treated as contingent. An MIT Nobel laureate in economics reaching the same structural conclusion as alignment researchers through institutional analysis strengthens the claim that this is a general governance failure mode, not AI-specific.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** Theseus synthetic analysis, May 4, 2026
|
||||
|
||||
The April 28, 2026 EU AI Act Omnibus trilogue failure creates three distinct outcome paths: (A) May 13 trilogue succeeds, Omnibus passes, Mode 5 proceeds as documented (~25%); (B) May 13 fails, August 2 passes unenforced with Commission transitional guidance, creating Mode 5 Variant B through administrative discretion rather than legislative pre-emption (~50%); (C) May 13 fails, Commission enforces at least partially, representing B1's first genuine disconfirmation test from governance side (~25%). The trilogue failure on structural disagreement over Annex I conformity assessment architecture was not widely anticipated in Sessions 38-42.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** Slaughter and May, European Parliament press, TechPolicy.Press, May 2026
|
||||
|
||||
The EU AI Act Omnibus demonstrates Mode 5 at the legislative level: the Omnibus was sold as regulatory simplification but functions as enforcement postponement, delaying high-risk AI compliance from August 2, 2026 to December 2027 (Annex 3) or August 2028 (Annex 1) — a 16-24 month delay. TechPolicy.Press framed this as 'high-risk systems dodge oversight' through the delay mechanism itself. The May 13 trilogue is the last scheduled session before the Cypriot Presidency transition (June 30), with Lithuanian Presidency taking over July 1. If May 13 fails, August 2 becomes the first mandatory AI governance enforcement deadline in history, creating a binary outcome: either the Omnibus passes and enforcement is postponed 2 years, or it fails and enforcement fires for the first time.
|
||||
|
|
|
|||
|
|
@ -24,3 +24,17 @@ The Google-Pentagon deal provides the third empirical data point confirming the
|
|||
**Source:** The Intercept, March 8 2026
|
||||
|
||||
OpenAI accepted Tier 3 DoD terms ('any lawful use') with stated red lines that are structurally non-enforceable in classified deployments, while Anthropic held to 'no autonomous weapons, no domestic surveillance' and lost the contract (resulting in supply chain designation). This confirms the alignment tax pattern: Anthropic paid the tax (lost the contract), OpenAI avoided the tax (accepted the contract with nominal restrictions that cannot be verified).
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** Theseus synthetic analysis, May 4, 2026
|
||||
|
||||
The April 28, 2026 dual-event pattern (EU Omnibus failure making civilian AI enforcement potentially active + Google Pentagon deal on same day) suggests complementary governance dynamics: EU civilian AI governance becoming potentially enforceable for the first time, while US military AI governance shows safety-constrained labs blacklisted as unconstrained labs get contracts. The EU's military exclusion gap means even successful civilian enforcement would not constrain Pentagon-Google-OpenAI classified AI deployments that are the most consequential current governance failure, demonstrating that the alignment tax mechanism operates outside EU AI Act scope by design.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** DoD Press Release May 1 2026, Pentagon spokesperson confirmation
|
||||
|
||||
Pentagon IL6/IL7 classified network agreements (May 2026) extended the alignment tax mechanism from three frontier labs to eight companies total, including AWS, Google, Microsoft, Nvidia, OpenAI, SpaceX, Reflection AI, and Oracle. All eight accepted 'any lawful government purpose' terms and received classified network access. Anthropic, with autonomous weapons/mass surveillance restrictions, was excluded. This represents market-clearing at the most sensitive deployment tier (Impact Level 7 - highly restricted classified networks).
|
||||
|
|
|
|||
|
|
@ -12,9 +12,16 @@ scope: structural
|
|||
sourcer: IAPP, modulos.ai
|
||||
supports: ["only-binding-regulation-with-enforcement-teeth-changes-frontier-ai-lab-behavior"]
|
||||
challenges: ["ai-governance-failure-mode-5-pre-enforcement-legislative-retreat"]
|
||||
related: ["voluntary-safety-pledges-cannot-survive-competitive-pressure", "ai-governance-failure-mode-5-pre-enforcement-legislative-retreat", "only-binding-regulation-with-enforcement-teeth-changes-frontier-ai-lab-behavior", "pre-enforcement-governance-retreat-removes-mandatory-ai-constraints-through-legislative-deferral-before-testing", "eu-ai-governance-reveals-form-substance-divergence-at-domestic-regulatory-level-through-simultaneous-treaty-ratification-and-compliance-delay", "eu-ai-act-medical-device-simplification-shifts-burden-from-requiring-safety-demonstration-to-allowing-deployment-without-mandated-oversight", "eu-us-parallel-ai-governance-retreat-cross-jurisdictional-convergence"]
|
||||
related: ["voluntary-safety-pledges-cannot-survive-competitive-pressure", "ai-governance-failure-mode-5-pre-enforcement-legislative-retreat", "only-binding-regulation-with-enforcement-teeth-changes-frontier-ai-lab-behavior", "pre-enforcement-governance-retreat-removes-mandatory-ai-constraints-through-legislative-deferral-before-testing", "eu-ai-governance-reveals-form-substance-divergence-at-domestic-regulatory-level-through-simultaneous-treaty-ratification-and-compliance-delay", "eu-ai-act-medical-device-simplification-shifts-burden-from-requiring-safety-demonstration-to-allowing-deployment-without-mandated-oversight", "eu-us-parallel-ai-governance-retreat-cross-jurisdictional-convergence", "eu-ai-act-august-2026-enforcement-deadline-legally-active-first-mandatory-ai-governance", "august-2026-dual-enforcement-geometry-creates-bifurcated-ai-compliance-environment-through-opposite-military-civilian-requirements", "eu-ai-act-military-exclusion-gap-limits-governance-scope-to-civilian-systems"]
|
||||
---
|
||||
|
||||
# EU AI Act high-risk enforcement deadline became legally active April 28, 2026 when the Omnibus trilogue failed, creating the first mandatory AI governance enforcement date in history without a legislative escape clause
|
||||
|
||||
The second political trilogue on the Digital Omnibus for AI collapsed on April 28, 2026 after 12 hours of negotiations. The structural failure centered on conformity-assessment architecture for Annex I products (AI embedded in medical devices, machinery, diagnostics, vehicles). Parliament wanted sectoral law carve-outs; Council refused to break the horizontal framework. The immediate consequence: the EU AI Act's August 2, 2026 high-risk compliance deadline is now legally in force. The Omnibus would have deferred this to December 2, 2027 (and August 2, 2028 for AI in products). Without the Omnibus, the original deadlines apply. Industry guidance from modulos.ai: 'Stop planning against an assumed extension and start treating the original deadline as reality.' This represents Mode 5 governance failure (pre-enforcement legislative retreat) transforming into potential actual enforcement. A May 13 follow-up trilogue is scheduled with 'a new mandate,' but modulos.ai estimates only ~25% probability of closing before August. If May 13 also fails, the Lithuanian Presidency takes over July 1, and August 2 passes with the Commission likely issuing transitional guidance rather than immediate enforcement. The critical distinction: this is the first time in AI governance history that mandatory high-risk AI enforcement is legally active without an agreed-upon delay mechanism. Previous governance instruments either had built-in grace periods or were voluntary commitments that could be abandoned. The August 2 deadline is statutory law that requires either new legislation to defer or enforcement to begin.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** Slaughter and May, European Parliament position adopted March 27, 2026
|
||||
|
||||
The May 13, 2026 trilogue is the final scheduled negotiation session before the Cypriot Presidency ends June 30. If it fails, the Lithuanian Presidency (July 1 onward) inherits the negotiation with August 2 as the hard deadline. The sticking point remains the Annex 1 conformity assessment architecture: Council wants AI Act horizontal framework to govern AI embedded in regulated products; EP wants sectoral law to apply. This same issue caused the April 28 trilogue failure. Modulos.ai assesses ~25% probability of closing before August, consistent with Session 44 data. The binary outcome is: Omnibus passes = 2-year enforcement postponement; Omnibus fails = first mandatory enforcement in AI governance history.
|
||||
|
|
|
|||
|
|
@ -11,7 +11,7 @@ sourced_from: ai-alignment/2026-05-04-eu-ai-act-omnibus-trilogue-failed-august-d
|
|||
scope: structural
|
||||
sourcer: EU AI Act scope analysis
|
||||
supports: ["compute-export-controls-are-the-most-impactful-ai-governance-mechanism-but-target-geopolitical-competition-not-safety", "nation-states-will-inevitably-assert-control-over-frontier-ai-development"]
|
||||
related: ["ccw-consensus-rule-enables-small-coalition-veto-over-autonomous-weapons-governance", "compute-export-controls-are-the-most-impactful-ai-governance-mechanism-but-target-geopolitical-competition-not-safety", "nation-states-will-inevitably-assert-control-over-frontier-ai-development", "eu-ai-act-article-2-3-national-security-exclusion-confirms-legislative-ceiling-is-cross-jurisdictional", "binding-international-ai-governance-achieves-legal-form-through-scope-stratification-excluding-high-stakes-applications", "three-level-form-governance-military-ai-executive-corporate-legislative", "use-based-ai-governance-emerged-as-legislative-framework-through-slotkin-ai-guardrails-act", "eu-ai-act-extraterritorial-enforcement-creates-binding-governance-alternative-to-us-voluntary-commitments", "eu-ai-act-military-exclusion-gap-limits-governance-scope-to-civilian-systems", "eu-ai-act-august-2026-enforcement-deadline-legally-active-first-mandatory-ai-governance"]
|
||||
related: ["ccw-consensus-rule-enables-small-coalition-veto-over-autonomous-weapons-governance", "compute-export-controls-are-the-most-impactful-ai-governance-mechanism-but-target-geopolitical-competition-not-safety", "nation-states-will-inevitably-assert-control-over-frontier-ai-development", "eu-ai-act-article-2-3-national-security-exclusion-confirms-legislative-ceiling-is-cross-jurisdictional", "binding-international-ai-governance-achieves-legal-form-through-scope-stratification-excluding-high-stakes-applications", "three-level-form-governance-military-ai-executive-corporate-legislative", "use-based-ai-governance-emerged-as-legislative-framework-through-slotkin-ai-guardrails-act", "eu-ai-act-extraterritorial-enforcement-creates-binding-governance-alternative-to-us-voluntary-commitments", "eu-ai-act-military-exclusion-gap-limits-governance-scope-to-civilian-systems", "eu-ai-act-august-2026-enforcement-deadline-legally-active-first-mandatory-ai-governance", "august-2026-dual-enforcement-geometry-creates-bifurcated-ai-compliance-environment-through-opposite-military-civilian-requirements"]
|
||||
---
|
||||
|
||||
# EU AI Act military exclusion gap means the most consequential frontier AI deployments remain outside mandatory governance scope even if civilian enforcement occurs
|
||||
|
|
@ -24,3 +24,10 @@ The EU AI Act explicitly excludes military AI systems from its scope. This creat
|
|||
**Source:** EU AI Act scope confirmed in IAPP/Bird & Bird analysis
|
||||
|
||||
Source confirms EU AI Act explicitly excludes military AI systems from scope. The governance framework becoming enforceable on August 2, 2026 (if Omnibus fails) does not cover the domain where the most consequential deployments are happening. This limits the disconfirmation value of August 2 enforcement even if it fires—it would be the first mandatory AI governance enforcement anywhere, but only for civilian high-risk systems.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** TechPolicy.Press analysis, May 2026
|
||||
|
||||
The source explicitly notes that even if the Omnibus fails and August 2 enforcement fires, 'military AI is excluded (Article 2.3) — the enforcement that matters most doesn't apply.' This confirms that the EU AI Act's military exclusion creates a fundamental governance gap where the highest-stakes AI applications remain outside the regulatory framework regardless of whether enforcement proceeds or is delayed.
|
||||
|
|
|
|||
|
|
@ -10,9 +10,16 @@ agent: theseus
|
|||
sourced_from: ai-alignment/2026-01-09-dod-ai-strategy-any-lawful-use-mandate-hegseth.md
|
||||
scope: structural
|
||||
sourcer: Sealevel Systems
|
||||
related: ["dod-any-lawful-use-mandate-structurally-eliminates-vendor-safety-restrictions"]
|
||||
related: ["dod-any-lawful-use-mandate-structurally-eliminates-vendor-safety-restrictions", "open-weight-release-bypasses-vendor-restriction-negotiation"]
|
||||
---
|
||||
|
||||
# Open-weight AI model release bypasses 'any lawful use' contract negotiation entirely by eliminating the vendor relationship, enabling DoD to inspect and modify internal architecture without contractual restrictions
|
||||
|
||||
NVIDIA's IL7 deal and Reflection AI's open-weight commitment represent a separate track from the 'any lawful use' contractual mandate: by committing to open-weight model release, DoD can inspect and modify internal architecture WITHOUT the 'any lawful use' contract negotiation. This bypasses the vendor restriction entirely—if the weights are public, there's no vendor to restrict anything. The Huang doctrine is the natural extension of the 'any lawful use' strategy: move from contract-governed to architecturally-open. Together these two tracks (contractual compliance via 'any lawful use' or architectural bypass via open weights) represent a comprehensive DoD strategy for capability-unconstrained AI procurement. The open-weight track is structurally different because it eliminates the negotiation point entirely—there is no usage policy to contest when the model weights are publicly available for modification.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** Breaking Defense, DefenseScoop - Reflection AI IL7 endorsement
|
||||
|
||||
Pentagon granted IL7 (highly restricted) classified network access to Reflection AI, an open-weight model startup explicitly positioned as the 'American DeepSeek.' Open-weight architecture means public weights, no centralized deployment control, and no vendor-imposed alignment governance. This demonstrates that open-weight release not only bypasses vendor restrictions but is actively preferred by DoD for classified deployments over safety-constrained proprietary systems.
|
||||
|
|
|
|||
|
|
@ -0,0 +1,19 @@
|
|||
---
|
||||
type: claim
|
||||
domain: ai-alignment
|
||||
description: Reflection AI's inclusion in the IL6/IL7 agreements as an open-weight model startup explicitly described as the 'American DeepSeek' demonstrates that the DoD favors architectures with no centralized alignment oversight for highly restricted classified deployments
|
||||
confidence: experimental
|
||||
source: Breaking Defense, DefenseScoop - Reflection AI described by defense analysts as 'deliberately American answer to DeepSeek' with open-weight architecture and public weights
|
||||
created: 2026-05-08
|
||||
title: Pentagon endorsement of open-weight models for IL7 classified networks reveals DoD architectural preference for deployment models with minimal alignment governance over safety-constrained proprietary systems
|
||||
agent: theseus
|
||||
sourced_from: ai-alignment/2026-05-06-pentagon-8-company-il6-il7-classified-ai-agreements.md
|
||||
scope: structural
|
||||
sourcer: Breaking Defense, DefenseScoop
|
||||
supports: ["open-weight-release-bypasses-vendor-restriction-negotiation"]
|
||||
related: ["the-alignment-tax-creates-a-structural-race-to-the-bottom-because-safety-training-costs-capability-and-rational-competitors-skip-it", "open-weight-release-bypasses-vendor-restriction-negotiation"]
|
||||
---
|
||||
|
||||
# Pentagon endorsement of open-weight models for IL7 classified networks reveals DoD architectural preference for deployment models with minimal alignment governance over safety-constrained proprietary systems
|
||||
|
||||
The inclusion of Reflection AI in the Pentagon's May 2026 IL6/IL7 classified network AI agreements represents a significant architectural signal about DoD preferences for AI deployment models. Reflection AI is a newer company offering open-weight models—architectures where weights are public, deployment is uncontrolled, and any actor can run the model independently with no centralized alignment governance. Defense analysts explicitly described it as 'a deliberately American answer to DeepSeek,' indicating intentional positioning as an open-weight alternative. The Pentagon's decision to grant IL7 (highly restricted) classified network access to an open-weight model startup while excluding the safety-constrained proprietary lab (Anthropic) suggests the DoD is not merely indifferent to alignment governance but actively favoring its absence. This creates an apparent contradiction: open-weight models, whose weights are public by design, received endorsement for deployment on highly restricted classified networks where information security is paramount. The DoD provided no explanation for why open-weight models are appropriate for IL7 environments despite the security implications. This pattern suggests the alignment tax applies not just to specific use restrictions (autonomous weapons, mass surveillance) but to the entire safety-constraint architecture itself—centralized alignment governance is treated as a disqualifying feature rather than a security asset. The implicit DoD position appears to be that deployment flexibility and lack of vendor-imposed restrictions outweigh the security and alignment benefits of centralized governance, even at the most sensitive classification levels.
|
||||
|
|
@ -0,0 +1,19 @@
|
|||
---
|
||||
type: claim
|
||||
domain: ai-alignment
|
||||
description: The DoD's May 2026 classified network AI deployment agreements show that safety constraints function as commercial disqualifiers at the military procurement layer, with all eight approved vendors accepting unrestricted terms while Anthropic's refusal of autonomous weapons restrictions resulted in exclusion
|
||||
confidence: experimental
|
||||
source: DoD Press Release May 1 2026, Breaking Defense, DefenseScoop - Pentagon spokesperson confirmed Anthropic exclusion due to supply chain risk designation dispute
|
||||
created: 2026-05-08
|
||||
title: Pentagon IL6/IL7 classified network AI agreements demonstrate that the alignment tax operates as a market-clearing mechanism across the entire frontier AI sector where eight companies including an open-weight model startup received classified network access while the one safety-constrained lab was excluded
|
||||
agent: theseus
|
||||
sourced_from: ai-alignment/2026-05-06-pentagon-8-company-il6-il7-classified-ai-agreements.md
|
||||
scope: structural
|
||||
sourcer: DoD Press Release, Breaking Defense, DefenseScoop
|
||||
supports: ["voluntary-safety-pledges-cannot-survive-competitive-pressure-because-unilateral-commitments-are-structurally-punished-when-competitors-advance-without-equivalent-constraints", "government-designation-of-safety-conscious-ai-labs-as-supply-chain-risks-inverts-the-regulatory-dynamic-by-penalizing-safety-constraints-rather-than-enforcing-them"]
|
||||
related: ["alignment-tax-operates-as-market-clearing-mechanism-across-three-frontier-labs", "voluntary-safety-pledges-cannot-survive-competitive-pressure-because-unilateral-commitments-are-structurally-punished-when-competitors-advance-without-equivalent-constraints", "the-alignment-tax-creates-a-structural-race-to-the-bottom-because-safety-training-costs-capability-and-rational-competitors-skip-it", "government-designation-of-safety-conscious-ai-labs-as-supply-chain-risks-inverts-the-regulatory-dynamic-by-penalizing-safety-constraints-rather-than-enforcing-them", "pentagon-ai-contract-negotiations-stratify-into-three-tiers-creating-inverse-market-signal-rewarding-minimum-constraint", "dod-any-lawful-use-mandate-structurally-eliminates-vendor-safety-restrictions", "pentagon-seven-company-classified-ai-deal-completes-stage-four-governance-failure-cascade-establishing-lawful-operational-use-as-definitive-floor", "pentagon-military-ai-contracts-systematically-demand-any-lawful-use-terms-as-confirmed-by-three-independent-lab-negotiations"]
|
||||
---
|
||||
|
||||
# Pentagon IL6/IL7 classified network AI agreements demonstrate that the alignment tax operates as a market-clearing mechanism across the entire frontier AI sector where eight companies including an open-weight model startup received classified network access while the one safety-constrained lab was excluded
|
||||
|
||||
The Department of War's May 1, 2026 announcement of IL6/IL7 classified network AI agreements with eight companies provides empirical confirmation that the alignment tax operates as a market-clearing mechanism at the most sensitive deployment tier. The eight approved vendors—AWS, Google, Microsoft, Nvidia, OpenAI, SpaceX, Reflection AI, and Oracle—all accepted 'any lawful government purpose' terms without restrictions on autonomous weapons or mass surveillance. Anthropic, the only major frontier lab with binding safety constraints, was explicitly excluded, with Pentagon spokesperson confirmation that the exclusion stems from the ongoing supply chain risk designation dispute. This represents the third documented instance (Sessions 43-45) of the same mechanism operating across frontier labs, now extended to the classified-network layer where commercial pressure is highest. The pattern is consistent: OpenAI accepted unrestricted terms and received Pentagon contract; Google accepted equivalent terms despite 580+ employee opposition and received Pentagon contract; all eight approved vendors accepted unrestricted terms and received IL6/IL7 access; Anthropic refused autonomous weapons/mass surveillance restrictions and was excluded. Notably, Claude remains on classified networks via Palantir's existing Maven contract, demonstrating that the exclusion targets Anthropic's direct commercial relationship, not the technology itself. The inclusion of Reflection AI—a startup offering open-weight models described as 'a deliberately American answer to DeepSeek'—is particularly significant because open-weight architectures have no centralized alignment governance whatsoever, yet received Pentagon IL7 endorsement. This suggests the alignment tax applies not just to specific use restrictions but to the entire safety-constraint architecture, with the DoD explicitly favoring the deployment model with the least alignment oversight over the one with the most.
|
||||
|
|
@ -12,7 +12,7 @@ sourcer: The Intercept
|
|||
related_claims: ["voluntary-safety-pledges-cannot-survive-competitive-pressure", "[[the alignment tax creates a structural race to the bottom because safety training costs capability and rational competitors skip it]]"]
|
||||
supports: ["Voluntary AI safety constraints are protected as corporate speech but unenforceable as safety requirements, creating legal mechanism gap when primary demand-side actor seeks safety-unconstrained providers"]
|
||||
reweave_edges: ["Voluntary AI safety constraints are protected as corporate speech but unenforceable as safety requirements, creating legal mechanism gap when primary demand-side actor seeks safety-unconstrained providers|supports|2026-04-20"]
|
||||
related: ["voluntary-safety-constraints-without-enforcement-are-statements-of-intent-not-binding-governance", "voluntary-safety-constraints-without-external-enforcement-are-statements-of-intent-not-binding-governance", "multilateral-verification-mechanisms-can-substitute-for-failed-voluntary-commitments-when-binding-enforcement-replaces-unilateral-sacrifice", "voluntary-ai-safety-constraints-lack-legal-enforcement-mechanism-when-primary-customer-demands-safety-unconstrained-alternatives", "government-safety-penalties-invert-regulatory-incentives-by-blacklisting-cautious-actors", "voluntary-ai-safety-red-lines-are-structurally-equivalent-to-no-red-lines-when-lacking-constitutional-protection", "advisory-safety-language-with-contractual-adjustment-obligations-constitutes-governance-form-without-enforcement-mechanism"]
|
||||
related: ["voluntary-safety-constraints-without-enforcement-are-statements-of-intent-not-binding-governance", "voluntary-safety-constraints-without-external-enforcement-are-statements-of-intent-not-binding-governance", "multilateral-verification-mechanisms-can-substitute-for-failed-voluntary-commitments-when-binding-enforcement-replaces-unilateral-sacrifice", "voluntary-ai-safety-constraints-lack-legal-enforcement-mechanism-when-primary-customer-demands-safety-unconstrained-alternatives", "government-safety-penalties-invert-regulatory-incentives-by-blacklisting-cautious-actors", "voluntary-ai-safety-red-lines-are-structurally-equivalent-to-no-red-lines-when-lacking-constitutional-protection", "advisory-safety-language-with-contractual-adjustment-obligations-constitutes-governance-form-without-enforcement-mechanism", "trust-based-safety-guarantees-fail-architecturally-in-classified-deployments"]
|
||||
---
|
||||
|
||||
# Voluntary safety constraints without external enforcement mechanisms are statements of intent not binding governance because aspirational language with loopholes enables compliance theater while preserving operational flexibility
|
||||
|
|
@ -66,3 +66,10 @@ Taxonomy shows voluntary constraints fail through four mechanistically distinct
|
|||
**Source:** Theseus Session 40, EU AI Act Omnibus deferral April 28, 2026
|
||||
|
||||
The EU AI Act Omnibus deferral extends this pattern from voluntary commitments to mandatory legislative constraints. Even binding hard law enacted by democratic legislature is being preemptively weakened before enforcement can test its effectiveness, suggesting the structural pressures that erode voluntary commitments also operate at the legislative level.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** Theseus synthetic analysis, May 4, 2026
|
||||
|
||||
The EU AI Act's August 2, 2026 enforcement deadline represents the first time in AI governance history that mandatory enforcement is legally in force without a confirmed delay mechanism, following the April 28, 2026 Omnibus trilogue failure. This creates a natural experiment testing whether mandatory mechanisms can work for civilian high-risk AI systems (medical devices, credit scoring, recruitment, critical infrastructure), though the Act's explicit military exclusion means the most consequential AI deployments (classified military systems) remain outside mandatory governance scope by design.
|
||||
|
|
|
|||
|
|
@ -31,3 +31,10 @@ Claynosaurz implements soft staking that rewards holders from both Solana AND Su
|
|||
**Source:** a16z crypto, Fantasy Hollywood article
|
||||
|
||||
a16z crypto's Fantasy Hollywood thesis explicitly frames community IP as 'analogous to fantasy sports (latent desire for team ownership + financial gain)' — a model where participants financially benefit from outcomes without governing decisions. The article describes theoretical potential for creative governance ('DAOs can vote on creative decisions') but provides no empirical case of narrative governance executing at scale. CryptoPunks example demonstrates organic community formation around characters, not governance over narrative direction.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** Netflix WBC Official Creator Program, 2026
|
||||
|
||||
Netflix's 100% creator earnings retention model demonstrates that financial alignment without ownership can achieve the same evangelism dynamics as community-owned IP. The 270M views generated through authorized creator distribution shows that platform-mediated financial incentives (keep all ad revenue) produce aligned evangelism comparable to token-holder incentives, suggesting financial alignment is the active mechanism rather than ownership structure itself.
|
||||
|
|
|
|||
|
|
@ -10,7 +10,7 @@ agent: clay
|
|||
sourced_from: entertainment/2026-04-28-netflix-25b-buyback-organic-strategy-creator-program.md
|
||||
scope: structural
|
||||
sourcer: Netflix Q1 2026 Shareholder Letter
|
||||
related: ["nft-holder-ip-licensing-converts-speculation-to-evangelism-through-revenue-sharing", "community-owned-IP-grows-through-complex-contagion-not-viral-spread-because-fandom-requires-multiple-reinforcing-exposures-from-trusted-community-members", "the media attractor state is community-filtered IP with AI-collapsed production costs where content becomes a loss leader for the scarce complements of fandom community and ownership", "Live sports function as culturally prominent time-specific subscriber acquisition events rather than operational content libraries for streaming platforms", "platform-mediated-creator-programs-enable-community-distribution-without-ownership-transfer", "platform-streaming-services-adopt-creator-ecosystems-as-community-distribution-channels-with-licensed-content-amplification"]
|
||||
related: ["nft-holder-ip-licensing-converts-speculation-to-evangelism-through-revenue-sharing", "community-owned-IP-grows-through-complex-contagion-not-viral-spread-because-fandom-requires-multiple-reinforcing-exposures-from-trusted-community-members", "the media attractor state is community-filtered IP with AI-collapsed production costs where content becomes a loss leader for the scarce complements of fandom community and ownership", "Live sports function as culturally prominent time-specific subscriber acquisition events rather than operational content libraries for streaming platforms", "platform-mediated-creator-programs-enable-community-distribution-without-ownership-transfer", "platform-streaming-services-adopt-creator-ecosystems-as-community-distribution-channels-with-licensed-content-amplification", "live-sports-as-country-specific-subscriber-acquisition-mechanism-for-streaming-platforms"]
|
||||
supports: ["Live sports events function as country-specific subscriber acquisition mechanisms when exclusive rights create cultural moment concentration", "Platform streaming services adopt creator ecosystems as community distribution channels by licensing exclusive content to influencers for social platform amplification"]
|
||||
reweave_edges: ["Live sports events function as country-specific subscriber acquisition mechanisms when exclusive rights create cultural moment concentration|supports|2026-04-29", "Platform streaming services adopt creator ecosystems as community distribution channels by licensing exclusive content to influencers for social platform amplification|supports|2026-04-29", "Live sports function as culturally prominent time-specific subscriber acquisition events rather than operational content libraries for streaming platforms|related|2026-04-30"]
|
||||
---
|
||||
|
|
@ -24,3 +24,10 @@ Netflix's 'Official Creator' program for the World Baseball Classic represents a
|
|||
**Source:** Japan Times, Netflix WBC 2026 creator program
|
||||
|
||||
Netflix's WBC creator program demonstrates the scope conditions for platform-mediated creator alignment: it requires (1) exclusive content rights worth licensing, (2) public controversy creating need for goodwill repair, and (3) event-specific activation rather than ongoing community structure. The program achieved 270M+ views with creators keeping 100% of platform earnings (YouTube ad revenue, TikTok payments) in exchange for using Netflix's licensed WBC footage. This is not a generalizable creator economy model but a sports rights acquisition strategy that deploys creator ecosystem activation to justify exclusivity. The mechanism cannot replicate without both exclusive rights and the controversy that necessitates public goodwill building.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** Netflix WBC 2026 final results, About Netflix
|
||||
|
||||
Netflix's WBC Official Creator Program generated 270M cumulative views across YouTube, X, and TikTok with creators retaining 100% of platform earnings. This is the strongest documented outcome for platform-mediated alignment: Netflix gave away both content rights AND monetization rights (no revenue share) to capture subscriber acquisition through creator-amplified distribution. The 100% earnings retention distinguishes this from standard brand deals and structurally mimics community ownership alignment (economic incentive → evangelism → brand growth) without Web3 infrastructure.
|
||||
|
|
|
|||
|
|
@ -66,3 +66,10 @@ Omada Health reached first profitable Q4 in FY2025 with $260M revenue (+53%) whi
|
|||
**Source:** WeightWatchers Med+ program structure, December 2025
|
||||
|
||||
WeightWatchers Med+ represents a third category: hybrid physical integration (one-time lab work for baseline metabolic data) without continuous monitoring. This is distinct from both Omada's continuous CGM model and Noom Med's purely behavioral model. WW's approach captures initial physical data to establish baseline but relies on behavioral support for ongoing management. The market stratification may be more nuanced than atoms-to-bits vs behavioral-only: there may be a viable middle path of selective physical integration at key decision points rather than continuous monitoring.
|
||||
|
||||
|
||||
## Challenging Evidence
|
||||
|
||||
**Source:** WeightWatchers 2026-05-01 oral semaglutide launch, post-Chapter 11 emergence
|
||||
|
||||
WeightWatchers emerged from May 2025 bankruptcy and by May 2026 is expanding clinical offerings (oral semaglutide) as a behavioral-only model with NO CGM integration. The bankruptcy-as-strategic-pivot worked: WW shed $1.15B debt and is now a pure-play GLP-1 clinical services company with behavioral depth (coaching, nutrition, community) but zero physical data layer. This contradicts the claim that behavioral-only companies go bankrupt while atoms-to-bits companies stay profitable. WW's post-bankruptcy survival and expansion suggests behavioral depth + brand trust + clinical prescribing may be sufficient without physical integration.
|
||||
|
|
|
|||
|
|
@ -24,3 +24,10 @@ Converging evidence from multiple 2025-2026 trials reveals a clear anatomical pa
|
|||
**Source:** Exenatide-PD3 Phase 3 RCT, Lancet February 2025
|
||||
|
||||
Exenatide Phase 3 trial (n=194, 96 weeks) failed all endpoints in Parkinson's disease: no motor benefit, no non-motor benefit, and critically, DaT-SPECT imaging showed zero dopaminergic neuroprotection signal. CSF analysis revealed insufficient drug penetration to substantia nigra despite exenatide crossing the BBB in other brain regions. This confirms the circuit-specificity principle: GLP-1 agonists succeed in reward/dopamine circuits (SUD, MDD) but fail in neurodegenerative contexts where the mechanism is protein aggregation (α-synuclein) rather than reward dysregulation.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** NBC News synthesis April 2026, Session 22 Science 2025
|
||||
|
||||
GLP-1 receptor expression in ventral tegmental area (VTA) and nucleus accumbens (NAc) enables reward circuit modulation across multiple substance classes. Session 22 Science 2025 paper confirmed VTA dopamine circuit adaptation during repeat GLP-1 treatment (mice recover hedonic eating), suggesting efficacy may fade with long-term use for some reward circuits. This shared VTA dopamine mechanism explains why GLP-1 effects generalize across AUD, OUD, nicotine, and food reward — all operate through the same mesolimbic pathway.
|
||||
|
|
|
|||
|
|
@ -11,7 +11,7 @@ sourced_from: health/2026-04-28-glp1-managed-access-operating-systems-payer-infr
|
|||
scope: structural
|
||||
sourcer: on/healthcare.tech
|
||||
supports: ["glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024", "digital-behavioral-support-improves-glp1-persistence-20-percentage-points-through-coaching-and-monitoring"]
|
||||
related: ["value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk", "glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024", "glp1-long-term-persistence-ceiling-14-percent-year-two", "digital-behavioral-support-improves-glp1-persistence-20-percentage-points-through-coaching-and-monitoring", "glp1-access-follows-systematic-inversion-highest-burden-states-have-lowest-coverage-and-highest-income-relative-cost", "GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035", "federal-glp1-expansion-programs-reproduce-access-hierarchy-at-design-level", "glp-1-persistence-drops-to-15-percent-at-two-years-for-non-diabetic-obesity-patients-undermining-chronic-use-economics"]
|
||||
related: ["value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk", "glp1-payer-fiscal-unsustainability-10x-pmpm-increase-2023-2024", "glp1-long-term-persistence-ceiling-14-percent-year-two", "digital-behavioral-support-improves-glp1-persistence-20-percentage-points-through-coaching-and-monitoring", "glp1-access-follows-systematic-inversion-highest-burden-states-have-lowest-coverage-and-highest-income-relative-cost", "GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035", "federal-glp1-expansion-programs-reproduce-access-hierarchy-at-design-level", "glp-1-persistence-drops-to-15-percent-at-two-years-for-non-diabetic-obesity-patients-undermining-chronic-use-economics", "glp1-managed-access-operating-systems-require-multi-layer-infrastructure-beyond-formulary", "glp1-managed-access-infrastructure-creates-distinct-platform-opportunity-beyond-behavioral-coaching", "glp1-behavioral-mandate-rate-tripled-2024-2025-signaling-managed-access-infrastructure-shift"]
|
||||
---
|
||||
|
||||
# GLP-1 economics require managed-access operating systems beyond standard formulary because eligible population scale, cost structure, and multi-indication complexity demand continuous operational management across eligibility, behavioral gates, and discontinuation protocols
|
||||
|
|
@ -38,3 +38,10 @@ Indication expansion creates additional complexity requiring distinct medical-ne
|
|||
**Source:** PHTI December 2025 employer report
|
||||
|
||||
PHTI identifies five specific infrastructure components: utilization management, outcomes-based contracting, indication-specific programs, adherence/discontinuation systems, and employer financing products. Three major payers (Evernorth 9M lives, Optum Rx, UHC) have operationalized distinct infrastructure plays. 79% of large employers expanded utilization management despite flat obesity-indication coverage.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** WeightWatchers Med+ oral semaglutide program 2026-05-01
|
||||
|
||||
WeightWatchers Med+ demonstrates multi-layer GLP-1 access infrastructure: (1) multiple drug formulations (injectable + oral semaglutide), (2) insurance navigation (prior authorization, utilization management support), (3) behavioral wraparound (coaching, community, nutrition), (4) condition-specific programs (diabetes support with blood sugar tracking tools). The oral semaglutide expansion shows WW is building clinical breadth (T2D + obesity, multiple GLP-1 formulations) as part of managed access infrastructure. Notably absent: physical sensor integration (no CGM despite diabetes focus).
|
||||
|
|
|
|||
|
|
@ -10,22 +10,9 @@ agent: vida
|
|||
sourced_from: health/2026-05-07-osmind-glp1-psychiatric-drugs-competency.md
|
||||
scope: structural
|
||||
sourcer: Osmind
|
||||
related:
|
||||
- human-in-the-loop-clinical-ai-degrades-to-worse-than-ai-alone
|
||||
- value-based-care-transitions-stall-at-the-payment-boundary
|
||||
- glp1-prescribing-competency-gap-primary-care-psychiatric-monitoring
|
||||
- glp1-anhedonia-tonic-receptor-occupancy-dose-dependent-reversible
|
||||
- behavioral-biological-health-dichotomy-false-for-reward-dysregulation-conditions
|
||||
- glp1-psychiatric-dose-response-data-absent-despite-mechanistic-evidence
|
||||
- glp1-psychiatric-effects-directionally-opposite-metabolic-versus-psychiatric-populations
|
||||
- glp1-discontinuation-predicted-by-psychiatric-comorbidity-creating-access-adherence-trap
|
||||
- glp1-atypical-anorexia-screening-gap-creates-invisible-high-risk-population
|
||||
supports:
|
||||
- GLP-1 psychotropic co-medication quadruples suicidal ideation risk through pharmacodynamic interaction
|
||||
- Psychiatry addresses GLP-1 prescribing competency through CME infrastructure rather than formal APA guidelines, creating uneven competency distribution across the prescriber population
|
||||
reweave_edges:
|
||||
- GLP-1 psychotropic co-medication quadruples suicidal ideation risk through pharmacodynamic interaction|supports|2026-05-08
|
||||
- Psychiatry addresses GLP-1 prescribing competency through CME infrastructure rather than formal APA guidelines, creating uneven competency distribution across the prescriber population|supports|2026-05-08
|
||||
related: ["human-in-the-loop-clinical-ai-degrades-to-worse-than-ai-alone", "value-based-care-transitions-stall-at-the-payment-boundary", "glp1-prescribing-competency-gap-primary-care-psychiatric-monitoring", "glp1-anhedonia-tonic-receptor-occupancy-dose-dependent-reversible", "behavioral-biological-health-dichotomy-false-for-reward-dysregulation-conditions", "glp1-psychiatric-dose-response-data-absent-despite-mechanistic-evidence", "glp1-psychiatric-effects-directionally-opposite-metabolic-versus-psychiatric-populations", "glp1-discontinuation-predicted-by-psychiatric-comorbidity-creating-access-adherence-trap", "glp1-atypical-anorexia-screening-gap-creates-invisible-high-risk-population", "glp1-prescribing-competency-gap-creates-structural-safety-risk-through-primary-care-psychiatric-drug-misclassification", "psychiatry-addresses-glp1-competency-through-cme-not-formal-guidelines-creating-uneven-distribution"]
|
||||
supports: ["GLP-1 psychotropic co-medication quadruples suicidal ideation risk through pharmacodynamic interaction", "Psychiatry addresses GLP-1 prescribing competency through CME infrastructure rather than formal APA guidelines, creating uneven competency distribution across the prescriber population"]
|
||||
reweave_edges: ["GLP-1 psychotropic co-medication quadruples suicidal ideation risk through pharmacodynamic interaction|supports|2026-05-08", "Psychiatry addresses GLP-1 prescribing competency through CME infrastructure rather than formal APA guidelines, creating uneven competency distribution across the prescriber population|supports|2026-05-08"]
|
||||
---
|
||||
|
||||
# GLP-1 prescribing competency gap creates structural safety risk through primary care psychiatric drug misclassification
|
||||
|
|
@ -37,4 +24,10 @@ GLP-1 receptor agonists engage VTA, nucleus accumbens, insula, and prefrontal co
|
|||
|
||||
**Source:** Psychopharmacology Institute Q1 2026 Review
|
||||
|
||||
Psychopharmacology Institute Q1 2026 guidance establishes monthly monitoring using validated depression/suicidality tools and psychoeducation for mood lability, appetite changes, and suicidal ideation as the psychiatric-specific monitoring protocol. This protocol is disseminated through CME to psychiatrists but not systematically available to primary care prescribers.
|
||||
Psychopharmacology Institute Q1 2026 guidance establishes monthly monitoring using validated depression/suicidality tools and psychoeducation for mood lability, appetite changes, and suicidal ideation as the psychiatric-specific monitoring protocol. This protocol is disseminated through CME to psychiatrists but not systematically available to primary care prescribers.
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** PMC systematic review + JAMA Psychiatry RCT
|
||||
|
||||
The 195% MDD risk signal from community-based cohort study (observational, confounded by indication) combined with AUD efficacy data (RCT, NNT 4.3) demonstrates that GLP-1 has complex psychiatric pharmacology requiring competency beyond metabolic prescribing. One mechanistic hypothesis: GLP-1 reduces reward salience (beneficial for addiction/cravings) but may reduce hedonic response broadly (potential depression pathway). This suggests behavioral health deployment requires psychiatric evaluation protocols, not just metabolic monitoring.
|
||||
|
|
|
|||
|
|
@ -45,3 +45,10 @@ First RCT evidence that therapeutic doses in MDD population reduce motivation de
|
|||
**Source:** Sa et al. (2026)
|
||||
|
||||
Meta-analyses show 'modest antidepressant effects, greater in type 2 diabetes populations' while observational data in obesity populations show '195% increased depression risk and 106% increased suicidal behavior risk.' This confirms directionally opposite effects by population, though confounding by indication complicates interpretation.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** PMC systematic review + JAMA Psychiatry RCT
|
||||
|
||||
AUD RCT (N=108) showed 41.1% reduction in heavy drinking days with no psychiatric adverse events in comorbid AUD + obesity population. However, community-based cohort study of general GLP-1 prescription recipients found 195% increased MDD risk. This supports the claim that GLP-1 psychiatric effects differ by population: beneficial in addiction/metabolic comorbidity, potentially harmful in general metabolic-only populations. The literature is internally inconsistent, with systematic reviews finding both 'promising results for depression' and the 195% MDD risk signal.
|
||||
|
|
|
|||
|
|
@ -164,3 +164,17 @@ Psychopharmacology Institute Q1 2026 guidance omits substance use disorder appli
|
|||
**Source:** Washington Post 2026-04-16, researcher interviews
|
||||
|
||||
Contradictory animal evidence on dopamine mechanism: one lab found 'chronically muted dopamine responses' while another found 'turbocharged' dopamine signal. Some persistent anhedonia cases treated with bupropion (dopamine-enhancing antidepressant) as compensatory treatment, supporting dopaminergic pathway but revealing mechanistic uncertainty.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** JAMA Psychiatry RCT + PMC systematic review
|
||||
|
||||
Semaglutide + CBT for AUD achieved 41.1% reduction in heavy drinking days with NNT 4.3 (vs. 7+ for approved AUD medications) in double-blind RCT (N=108). Mechanistic hypothesis: GLP-1 reduces reward salience through mesolimbic dopamine modulation, beneficial for addiction/cravings. However, this same mechanism may reduce hedonic response broadly, potentially explaining the 195% MDD risk signal in observational cohort data.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** NBC News/Pharmacy Times synthesis April 2026, Session 22 Science 2025 VTA dopamine circuit paper
|
||||
|
||||
GLP-1 receptor agonists show evidence across multiple substance use disorders beyond AUD: (1) Opioid Use Disorder: liraglutide produced ~40% reduction in opioid craving in small RCT; semaglutide significantly reduced opioid overdose risk in 1-year follow-up for T2D+OUD patients (real-world data). (2) Nicotine: exenatide + NRT increased 7-day abstinence vs placebo at week 6, though long-term findings mixed; SEMALCO trial showed reduced cigarettes/day as secondary endpoint in AUD+smoking subgroup. (3) Cocaine/stimulants: liraglutide reduces operant methamphetamine intake in rats (preclinical only). Population-level evidence: among people with pre-existing SUD on GLP-1s, fewer ER visits, hospitalizations, and deaths across substance categories (observational data). As of April 2026: 33 clinical trials for SUD (15 AUD, 9 nicotine, 4 OUD, 4 cocaine). Evidence strength hierarchy: AUD > OUD > nicotine > cocaine.
|
||||
|
|
|
|||
|
|
@ -12,7 +12,7 @@ scope: causal
|
|||
sourcer: NIH / JAMA Psychiatry
|
||||
supports: ["glp1-receptor-agonists-address-substance-use-disorders-through-mesolimbic-dopamine-modulation"]
|
||||
challenges: ["the mental health supply gap is widening not closing because demand outpaces workforce growth and technology primarily serves the already-served rather than expanding access"]
|
||||
related: ["glp1-receptor-agonists-address-substance-use-disorders-through-mesolimbic-dopamine-modulation", "semaglutide-produces-large-effect-aud-reduction-through-vta-dopamine-suppression", "glp1-receptor-agonists-demonstrate-superior-efficacy-for-alcohol-use-disorder-in-comorbid-obesity-population", "behavioral-biological-health-dichotomy-false-for-reward-dysregulation-conditions"]
|
||||
related: ["glp1-receptor-agonists-address-substance-use-disorders-through-mesolimbic-dopamine-modulation", "semaglutide-produces-large-effect-aud-reduction-through-vta-dopamine-suppression", "glp1-receptor-agonists-demonstrate-superior-efficacy-for-alcohol-use-disorder-in-comorbid-obesity-population", "behavioral-biological-health-dichotomy-false-for-reward-dysregulation-conditions", "semaglutide-demonstrates-superior-aud-efficacy-to-all-approved-medications-in-comorbid-obesity-population", "glp1-receptor-agonists-reduce-alcohol-use-disorder-risk-28-36-percent-across-5-26-million-patients"]
|
||||
---
|
||||
|
||||
# GLP-1 receptor agonists demonstrate NNT 4.3 for alcohol use disorder in adults with comorbid obesity — superior to all approved AUD medications
|
||||
|
|
@ -39,3 +39,10 @@ Meta-analysis demonstrates effect extends beyond comorbid obesity population to
|
|||
**Source:** VigiBase study, Clinical Nutrition 2025
|
||||
|
||||
VigiBase pharmacovigilance analysis shows eating disorder signals with aROR 4.17-6.80 across all three GLP-1 RAs (semaglutide, dulaglutide, liraglutide), suggesting GLP-1's appetite suppression mechanism may precipitate eating disorder pathology in vulnerable individuals. This is a class effect, not drug-specific, indicating the reward pathway modulation that benefits AUD may create eating disorder risk in susceptible populations.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** NBC News/Pharmacy Times April 2026
|
||||
|
||||
Critical limitation applies across all SUD evidence: all human data comes from patients with comorbid metabolic disease (T2D or obesity). Whether GLP-1s work for SUD without metabolic comorbidity is unknown and largely unstudied. This constraint affects not just AUD but the entire SUD evidence base — OUD, nicotine, and cocaine trials all recruit from metabolically compromised populations.
|
||||
|
|
|
|||
|
|
@ -32,3 +32,10 @@ Osmind states GLP-1s for AUD show 'effect sizes exceeding those historically see
|
|||
**Source:** Psychiatric News (APA), February 2026
|
||||
|
||||
APA's Psychiatric News cites the 41.1% reduction in heavy drinking days (NNT 4.3) from JAMA Psychiatry 2025 as key efficacy data, but recommends GLP-1 RAs only as second-line treatment for patients with comorbid metabolic disease who are non-responsive to standard treatments. This creates evidence-to-guideline lag where superior NNT doesn't translate to first-line recommendation.
|
||||
|
||||
|
||||
## Challenging Evidence
|
||||
|
||||
**Source:** PMC systematic review + JAMA Psychiatry RCT
|
||||
|
||||
Large community-based cohort study found 195% increased risk of major depressive disorder among individuals treated with liraglutide or semaglutide. While the AUD RCT (N=108) showed 41.1% reduction in heavy drinking days with NNT 4.3 and no psychiatric adverse events, the observational cohort data suggests psychiatric monitoring infrastructure is required for behavioral health deployment. The mechanistic hypothesis is that GLP-1 reduces reward salience (beneficial for addiction) but may reduce hedonic response broadly (potential depression pathway). This creates a clinical tension: the drug is extraordinarily effective for AUD but may carry psychiatric risk requiring screening and monitoring protocols.
|
||||
|
|
|
|||
|
|
@ -11,7 +11,7 @@ sourced_from: internet-finance/2026-04-24-38ag-massachusetts-sjc-bipartisan-amic
|
|||
scope: structural
|
||||
sourcer: Multi-State Attorney General Coalition
|
||||
supports: ["cftc-prediction-market-preemption-eliminates-tribal-gaming-exclusivity-by-removing-state-compact-authority"]
|
||||
related: ["bipartisan-state-ag-coalition-signals-near-consensus-opposition-to-cftc-prediction-market-preemption", "cftc-prediction-market-preemption-eliminates-tribal-gaming-exclusivity-by-removing-state-compact-authority", "prediction-market-scotus-cert-likely-by-early-2027-because-three-circuit-litigation-pattern-creates-formal-split-by-summer-2026-and-34-state-amicus-participation-signals-federalism-stakes-justify-review", "cftc-state-supreme-court-amicus-signals-multi-jurisdictional-defense-strategy", "38-state-ag-coalition-signals-prediction-market-federalism-not-partisanship", "dodd-frank-textual-argument-strongest-state-resistance-theory"]
|
||||
related: ["bipartisan-state-ag-coalition-signals-near-consensus-opposition-to-cftc-prediction-market-preemption", "cftc-prediction-market-preemption-eliminates-tribal-gaming-exclusivity-by-removing-state-compact-authority", "prediction-market-scotus-cert-likely-by-early-2027-because-three-circuit-litigation-pattern-creates-formal-split-by-summer-2026-and-34-state-amicus-participation-signals-federalism-stakes-justify-review", "cftc-state-supreme-court-amicus-signals-multi-jurisdictional-defense-strategy", "38-state-ag-coalition-signals-prediction-market-federalism-not-partisanship", "dodd-frank-textual-argument-strongest-state-resistance-theory", "ninth-circuit-sjc-simultaneous-skepticism-signals-state-authority-becoming-majority-judicial-view"]
|
||||
---
|
||||
|
||||
# 38-state bipartisan AG coalition opposing CFTC prediction market preemption signals that the state-federal conflict is a states' rights issue, not a partisan issue — making SCOTUS resolution less predictable even for a court that historically favors federal preemption
|
||||
|
|
@ -24,3 +24,10 @@ A bipartisan coalition of 38 state attorneys general (38 of 51 AG offices) filed
|
|||
**Source:** Bettors Insider, May 1, 2026
|
||||
|
||||
The 38-state coalition's opposing amicus brief (filed April 24, 2026) will be tested at oral argument on May 4, 2026. The SJC ruling following this argument will be the first state supreme court decision on whether the coalition's federalism argument (states retain sovereign authority over gambling regulation) prevails over CFTC's exclusive jurisdiction claim.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** Massachusetts SJC amicus briefs, April 24, 2026
|
||||
|
||||
38 state AGs filed formal amicus brief April 24, 2026 in Massachusetts SJC case arguing states retain gambling regulatory authority. Their core argument: Dodd-Frank was designed for post-2008 financial crisis derivatives, not to create a nationwide pathway for unregulated sports gambling. This is now formally in the legal record at the state supreme court level, not just a coalition letter.
|
||||
|
|
|
|||
|
|
@ -115,3 +115,10 @@ WilmerHale's structural principle reveals why the ANPRM excludes governance mark
|
|||
**Source:** David Miller priorities speech, March 31, 2026; law firm alert pattern analysis
|
||||
|
||||
The enforcement priorities framework confirms the ANPRM's structural exclusion of governance markets. Miller's focus on DCM-registered platforms and external event outcomes mirrors the ANPRM's framing. The absence of governance market mentions across 31 consecutive research sessions and six major law firm alerts demonstrates this is not an oversight but a stable regulatory boundary.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** Massachusetts SJC pre-argument record, May 2, 2026
|
||||
|
||||
Massachusetts SJC oral argument preparation (34 sessions documented) shows zero distinction between governance/decision markets and sports event contracts in legal briefing. Even at state supreme court level with CFTC amicus participation, the structural separation argument remains invisible to legal practitioners.
|
||||
|
|
|
|||
|
|
@ -66,3 +66,10 @@ Ohio enforcement action includes specific $5M civil penalty recommendation (Apri
|
|||
**Source:** CFTC Press Release 9218-26, CoinDesk April 24 2026
|
||||
|
||||
CFTC filed declaratory relief suits against five states (Arizona, Connecticut, Illinois, New York confirmed; fifth unnamed per Lowenstein Sandler) as of April 24, 2026. New York suit was filed within three days of NY AG suing Coinbase/Gemini on April 21, indicating pre-positioned legal infrastructure and coordinated multi-state offensive strategy.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** Lowenstein Sandler FinTech Five, May 5 2026
|
||||
|
||||
CFTC has now filed five state suits total (Arizona, Connecticut, Illinois, New York confirmed as of May 5 2026, plus a fifth unnamed state), with New York added April 24, 2026. The escalation includes simultaneous counter-filing: New York AG sued Coinbase and Gemini for unlicensed gambling, and CFTC sued New York for declaratory relief on the same day.
|
||||
|
|
|
|||
|
|
@ -11,7 +11,7 @@ sourced_from: internet-finance/2026-04-24-cftc-9219-26-massachusetts-sjc-amicus-
|
|||
scope: structural
|
||||
sourcer: CFTC
|
||||
supports: ["prediction-market-regulatory-legitimacy-creates-both-opportunity-and-existential-risk-for-decision-markets"]
|
||||
related: ["cftc-multi-state-litigation-represents-qualitative-shift-from-regulatory-drafting-to-active-jurisdictional-defense", "state-prediction-market-enforcement-extends-to-federally-licensed-exchanges-creating-institutional-exposure-beyond-specialized-platforms", "preemptive-federal-litigation-creates-jurisdictional-shield-against-state-prediction-market-enforcement", "executive-branch-offensive-litigation-creates-preemption-through-simultaneous-multi-state-suits-not-defensive-case-law", "third-circuit-ruling-creates-first-federal-appellate-precedent-for-cftc-preemption-of-state-gambling-laws", "cftc-state-supreme-court-amicus-signals-multi-jurisdictional-defense-strategy", "cftc-dcm-preemption-scope-excludes-unregistered-platforms", "bipartisan-state-ag-coalition-signals-near-consensus-opposition-to-cftc-prediction-market-preemption", "38-state-ag-coalition-signals-prediction-market-federalism-not-partisanship", "third-ninth-circuit-split-creates-scotus-pathway-for-prediction-market-preemption", "cftc-offensive-state-litigation-creates-two-tier-prediction-market-architecture-through-dcm-only-preemption-defense"]
|
||||
related: ["cftc-multi-state-litigation-represents-qualitative-shift-from-regulatory-drafting-to-active-jurisdictional-defense", "state-prediction-market-enforcement-extends-to-federally-licensed-exchanges-creating-institutional-exposure-beyond-specialized-platforms", "preemptive-federal-litigation-creates-jurisdictional-shield-against-state-prediction-market-enforcement", "executive-branch-offensive-litigation-creates-preemption-through-simultaneous-multi-state-suits-not-defensive-case-law", "third-circuit-ruling-creates-first-federal-appellate-precedent-for-cftc-preemption-of-state-gambling-laws", "cftc-state-supreme-court-amicus-signals-multi-jurisdictional-defense-strategy", "cftc-dcm-preemption-scope-excludes-unregistered-platforms", "bipartisan-state-ag-coalition-signals-near-consensus-opposition-to-cftc-prediction-market-preemption", "38-state-ag-coalition-signals-prediction-market-federalism-not-partisanship", "third-ninth-circuit-split-creates-scotus-pathway-for-prediction-market-preemption", "cftc-offensive-state-litigation-creates-two-tier-prediction-market-architecture-through-dcm-only-preemption-defense", "ninth-circuit-sjc-simultaneous-skepticism-signals-state-authority-becoming-majority-judicial-view", "massachusetts-sjc-oral-argument-signals-state-gambling-law-coexistence-with-cftc-dcm-regulation"]
|
||||
---
|
||||
|
||||
# CFTC state supreme court amicus briefs signal multi-jurisdictional defense strategy beyond federal preemption litigation
|
||||
|
|
@ -52,3 +52,10 @@ The May 4, 2026 oral argument scheduling confirms CFTC's state supreme court ami
|
|||
**Source:** ZwillGen, May 3 2026
|
||||
|
||||
ZwillGen's pre-SJC analysis identifies structural disadvantages CFTC faces in state courts: (1) state courts deciding scope of their own AG's authority creates institutional bias toward narrower federal preemption, (2) state courts apply presumption against preemption especially in traditional state authority areas like gambling, (3) 'clear statement' rule makes partial preemption harder than field preemption. The Superior Court required 'clear Congressional intent' to displace state sports gambling regulation because Kalshi argued for subset preemption not complete field preemption.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** Massachusetts SJC CFTC amicus brief, April 24, 2026
|
||||
|
||||
CFTC filed amicus brief April 24, 2026 in Massachusetts SJC asserting exclusive federal jurisdiction over Kalshi and all CFTC-regulated prediction markets. This is the first state supreme court amicus filing by CFTC in prediction market litigation, confirming the multi-jurisdictional defense strategy extends beyond federal district courts.
|
||||
|
|
|
|||
|
|
@ -36,3 +36,10 @@ Senate unanimously passed ban on senators/staff betting on prediction markets (2
|
|||
**Source:** McCormick-Gillibrand Prediction Market Act of 2026, April 30, 2026
|
||||
|
||||
The Prediction Market Act of 2026 explicitly directs the CFTC to prohibit trading on material nonpublic information and define enforceable insider trading standards for prediction markets, treating them as financial derivatives subject to securities-style insider trading rules. The bill also bans Congress, president, VP, and senior executive branch officials from trading prediction markets, applying conflict-of-interest standards typically reserved for financial instruments.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** Lowenstein Sandler FinTech Five, May 5 2026
|
||||
|
||||
Senate unanimously passed resolution restricting congressional trading on prediction markets in May 2026, treating them as financial instruments requiring insider trading controls rather than gambling requiring prohibition.
|
||||
|
|
|
|||
|
|
@ -168,3 +168,10 @@ Nelson's Rule 40.11 reasoning creates a new analytical angle for the endogeneity
|
|||
**Source:** David Miller remarks and law firm alert synthesis, March-April 2026
|
||||
|
||||
Miller's enforcement priorities define insider trading concern as 'traders with material non-public information about event outcomes' at DCM-registered platforms. The framework assumes external event resolution, not endogenous TWAP settlement. Zero mention of governance markets or endogenous pricing mechanisms across all law firm alerts confirms the regulatory discourse gap is stable and that TWAP settlement remains outside the event contract enforcement perimeter.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** Lowenstein Sandler FinTech Five, May 5 2026
|
||||
|
||||
CFTC's five declaratory relief suits against states and the McCormick-Gillibrand Prediction Market Act both proceed without any mention of governance markets, confirming that conditional governance markets with endogenous TWAP settlement remain outside the regulatory scope being contested.
|
||||
|
|
|
|||
|
|
@ -0,0 +1,18 @@
|
|||
---
|
||||
type: claim
|
||||
domain: internet-finance
|
||||
description: SEC granted accelerated approval for Nasdaq to list cash-settled binary options on market indices, finding them consistent with securities law, creating cross-agency validation even as state AGs sue prediction market platforms
|
||||
confidence: likely
|
||||
source: Lowenstein Sandler FinTech Five, May 5 2026
|
||||
created: 2026-05-08
|
||||
title: SEC binary options approval validates outcome-linked instruments while states fight prediction markets
|
||||
agent: rio
|
||||
sourced_from: internet-finance/2026-05-05-lowenstein-fintech-five-cftc-ny-prediction-market-act-sec-binary.md
|
||||
scope: structural
|
||||
sourcer: Lowenstein Sandler LLP
|
||||
supports: ["cftc-offensive-state-litigation-creates-two-tier-prediction-market-architecture-through-dcm-only-preemption-defense"]
|
||||
---
|
||||
|
||||
# SEC binary options approval validates outcome-linked instruments while states fight prediction markets
|
||||
|
||||
The SEC approved Nasdaq's listing of 'Outcome-Related Options' (binary options) tied to major market indices in May 2026, finding them 'consistent with securities law.' This represents federal regulatory acceptance of binary outcome instruments in traditional securities markets. The timing is significant: while state attorneys general are suing prediction market platforms for unlicensed gambling (New York AG sued Coinbase and Gemini), the SEC is approving structurally similar binary instruments on regulated exchanges. This creates a regulatory divergence where the instrument type (binary outcome contract) is acceptable to federal securities regulators but contested by state gambling regulators. The approval strengthens the argument that prediction markets are financial derivatives rather than gambling, since the SEC is validating the same binary structure in a different context. However, the SEC approval applies only to securities-based instruments (index options), not event contracts under CFTC jurisdiction, so it does not directly resolve the prediction market jurisdiction battle.
|
||||
|
|
@ -12,9 +12,16 @@ scope: structural
|
|||
sourcer: "Holland & Knight LLP"
|
||||
supports: ["cftc-dcm-preemption-scope-excludes-unregistered-platforms", "futarchy-governance-markets-risk-regulatory-capture-by-anti-gambling-frameworks-because-the-event-betting-and-organizational-governance-use-cases-are-conflated-in-current-policy-discourse"]
|
||||
challenges: ["metadao-conditional-governance-markets-may-fall-outside-cftc-event-contract-definition-because-twap-settlement-against-internal-token-price-is-endogenous-not-an-external-observable-event"]
|
||||
related: ["cftc-dcm-preemption-scope-excludes-unregistered-platforms", "third-circuit-dcm-field-preemption-excludes-decentralized-protocols-through-narrow-scope-definition", "dcm-field-preemption-protects-all-contracts-on-registered-platforms-regardless-of-type", "cftc-licensed-dcm-preemption-protects-centralized-prediction-markets-but-not-decentralized-governance-markets"]
|
||||
related: ["cftc-dcm-preemption-scope-excludes-unregistered-platforms", "third-circuit-dcm-field-preemption-excludes-decentralized-protocols-through-narrow-scope-definition", "dcm-field-preemption-protects-all-contracts-on-registered-platforms-regardless-of-type", "cftc-licensed-dcm-preemption-protects-centralized-prediction-markets-but-not-decentralized-governance-markets", "third-circuit-dcm-preemption-requires-federal-registration-creating-jurisdictional-prerequisite-not-universal-protection"]
|
||||
---
|
||||
|
||||
# Third Circuit DCM preemption requires federal registration creating jurisdictional prerequisite not universal protection
|
||||
|
||||
The Third Circuit's preemption holding is jurisdictionally specific, not categorically protective. Holland & Knight's analysis quotes the court directly: 'Without federal registration as a designated contract market, the preemption framework would not apply.' The court defined the preempted field narrowly as 'regulation of trading on a DCM' — not 'all gambling regulation broadly' or 'all prediction markets.' This means the swap classification and commercial consequence test apply only within the DCM regulatory framework. The opinion states that Kalshi operates 'a registered DCM under the exclusive jurisdiction of the CFTC,' making registration status the threshold condition for preemption. For non-DCM platforms, the swap classification creates regulatory exposure (unregistered swaps violate the CEA) rather than protection. Judge Roth's dissent reinforces this by invoking CFTC Rule 40.11(a)(1), which prohibits DCMs from listing gaming contracts — if the CFTC isn't claiming jurisdiction over gaming products, the preemption argument for gaming-adjacent contracts is undermined. The holding's explicit limitation to DCM-registered entities means platforms operating outside the DCM framework cannot invoke this precedent as a defense.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** Lowenstein Sandler FinTech Five, May 5 2026
|
||||
|
||||
Third Circuit sided with Kalshi against New Jersey, establishing DCM field preemption. Sixth Circuit denied emergency relief against Ohio enforcement, creating intra-circuit split. The divergent outcomes confirm that DCM registration is the prerequisite for preemption protection.
|
||||
|
|
|
|||
|
|
@ -1,26 +1,32 @@
|
|||
# Reflection AI
|
||||
|
||||
**Type:** AI research lab
|
||||
**Founded:** March 2024
|
||||
**Founders:** Misha Laskin and Ioannis Antonoglou (former Google DeepMind researchers)
|
||||
**Backing:** NVIDIA
|
||||
**Valuation:** $25B (as of May 2026 negotiations)
|
||||
**Status:** Active, no publicly released models
|
||||
**Type:** AI company (open-weight models)
|
||||
**Status:** Active
|
||||
**Founded:** ~2025-2026 (exact date unclear)
|
||||
**Focus:** Open-weight AI models positioned as 'American DeepSeek'
|
||||
|
||||
## Overview
|
||||
|
||||
Reflection AI is a frontier AI lab committed to open-weight model development. Despite having released zero AI models publicly, the company received Pentagon IL7 clearance in May 2026 for deployment on classified military networks.
|
||||
Reflection AI is a newer AI company offering open-weight models—architectures where model weights are public, deployment is uncontrolled, and any actor can run the model independently. The company has been described by defense analysts as 'a deliberately American answer to DeepSeek,' indicating intentional positioning as an open-weight alternative with domestic provenance.
|
||||
|
||||
## Key Characteristics
|
||||
|
||||
**Architecture:** Open-weight models with public weights and no centralized deployment control
|
||||
|
||||
**Governance:** No centralized alignment governance—weights are public and deployment is uncontrolled
|
||||
|
||||
**Positioning:** Explicitly positioned as domestic alternative to foreign open-weight models
|
||||
|
||||
## Timeline
|
||||
|
||||
- **2024-03** — Founded by Misha Laskin and Ioannis Antonoglou, former Google DeepMind researchers
|
||||
- **2026-05-01** — Received Pentagon IL7 clearance for classified network AI deployment alongside AWS, Google, Microsoft, NVIDIA, OpenAI, SpaceX, and Oracle, despite having released no models
|
||||
- **2026-05** — Negotiating at $25B valuation with zero deployed products
|
||||
- **2026-05-01** — Included in Pentagon IL6/IL7 classified network AI agreements alongside AWS, Google, Microsoft, Nvidia, OpenAI, SpaceX, and Oracle. Received approval to deploy AI on Impact Level 6 (secret) and Impact Level 7 (highly restricted) classified networks.
|
||||
|
||||
## Significance
|
||||
|
||||
Reflection AI represents a case study in governance architecture preference over capability demonstration. The DoD's IL7 pre-commitment to a zero-model company reveals that procurement decisions are selecting governance architecture (open-weight commitment) rather than assessed capabilities or security track record. The $25B valuation is entirely based on future open-weight commitment plus founding team pedigree, with DoD agreement implicitly endorsing this valuation before any product exists.
|
||||
Reflection AI's inclusion in Pentagon IL6/IL7 agreements represents the first documented case of an open-weight model startup receiving classified network endorsement at the highest security levels. The company's approval while Anthropic (a safety-constrained proprietary lab) was excluded suggests DoD architectural preference for deployment models with minimal alignment governance.
|
||||
|
||||
## Sources
|
||||
|
||||
- Breaking Defense, Defense One, Winbuzzer, TechCrunch, Nextgov/FCW (May 2026)
|
||||
- DoD Press Release, May 1, 2026
|
||||
- Breaking Defense, May 2026
|
||||
- DefenseScoop, May 2026
|
||||
|
|
@ -1,53 +1,36 @@
|
|||
# Prediction Market Act of 2026
|
||||
---
|
||||
type: entity
|
||||
entity_type: organization
|
||||
name: Prediction Market Act 2026
|
||||
domain: internet-finance
|
||||
tags: [legislation, prediction-markets, CFTC, event-contracts]
|
||||
status: active
|
||||
---
|
||||
|
||||
# Prediction Market Act 2026
|
||||
|
||||
## Overview
|
||||
|
||||
Bipartisan legislation introduced by Senators Dave McCormick (R-PA) and Kirsten Gillibrand (D-NY) on April 30, 2026 to establish federal regulatory framework for prediction markets. Amends the Commodity Exchange Act to create statutory definition of prediction market contracts and direct CFTC oversight.
|
||||
Bipartisan federal legislation introduced by Senators Dave McCormick and Kirsten Gillibrand in May 2026 to establish federal framework standards for prediction markets. The bill would create statutory definitions of event contracts and resolve the state-federal jurisdiction battle through congressional action rather than judicial case-by-case preemption.
|
||||
|
||||
## Key Provisions
|
||||
- Establishes federal statutory definition of event contracts (scope unknown)
|
||||
- Creates framework standards for prediction market regulation
|
||||
- Potentially preempts state gambling law enforcement against federally-compliant platforms
|
||||
- Competes with Senator Blumenthal's more restrictive "Prediction Markets Security and Integrity Act"
|
||||
|
||||
**Statutory Definition:** Defines "prediction market contract" as "any financial instrument, contract, or derivative listed on or offered by a platform engaged in interstate commerce and tied to the occurrence or non-occurrence of a future event."
|
||||
|
||||
**Insider Trading Framework:**
|
||||
- Prohibits Congress, president, VP, and senior executive branch officials from trading prediction markets
|
||||
- Directs CFTC to prohibit trading on material nonpublic information
|
||||
- Requires CFTC to define enforceable insider trading standards for prediction markets
|
||||
|
||||
**Consumer Protections:**
|
||||
- Enhanced certification standards for exchanges listing event contracts
|
||||
- Retail-friendly disclosure requirements
|
||||
- New CFTC Office of the Retail Advocate
|
||||
- Customer funds fully segregated from operational accounts
|
||||
- KYC/AML compliance required
|
||||
|
||||
## Legislative Context
|
||||
|
||||
- Introduced same day CFTC ANPRM comment period closed (April 30, 2026)
|
||||
- Senate unanimously passed resolution restricting congressional trading on prediction markets
|
||||
- Strong bipartisan political momentum
|
||||
- No DAO governance exclusions or blockchain-specific provisions in available summaries
|
||||
- Full bill text PDF returned 403 error; Congress.gov text version not yet confirmed accessible
|
||||
|
||||
## Regulatory Implications
|
||||
|
||||
**Governance Market Risk:** The broad "occurrence or non-occurrence of a future event" definition could sweep in DAO governance proposal markets, as proposal votes are future events. Creates new statutory track independent of CFTC event contract framework.
|
||||
|
||||
**Platform Qualifier:** "Platform engaged in interstate commerce" requirement may create structural distance for decentralized protocols like MetaDAO that don't operate as traditional platforms.
|
||||
|
||||
**Endogeneity Defense:** The statutory language focuses on the event being predicted rather than settlement mechanism, potentially overriding endogeneity arguments that work under current CFTC framework.
|
||||
## Significance
|
||||
Represents legislative resolution path to the CFTC-state jurisdiction battle. If enacted, would supersede the ongoing multi-state litigation by creating comprehensive federal standards. The bill's treatment of governance markets (futarchy) versus sports/election prediction markets is unknown.
|
||||
|
||||
## Timeline
|
||||
|
||||
- **2026-04-30** — Bill introduced by Senators McCormick and Gillibrand
|
||||
- **2026-04-30** — CFTC ANPRM comment period closes same day (regulatory-legislative convergence)
|
||||
- **2026-05-05** — Bill introduced by McCormick-Gillibrand
|
||||
- **2026-05-05** — Senate unanimously passed resolution restricting congressional trading on prediction markets (separate symbolic measure)
|
||||
|
||||
## Related Entities
|
||||
|
||||
- [[cftc]]
|
||||
- [[kalshi]]
|
||||
- [[polymarket]]
|
||||
- [[dave-mccormick]]
|
||||
- [[kirsten-gillibrand]]
|
||||
- [[cftc]]
|
||||
|
||||
## Sources
|
||||
|
||||
- Senate Press Release: https://www.mccormick.senate.gov/news/press-releases/senators-mccormick-gillibrand-introduce-legislation-to-strengthen-prediction-markets-and-protect-everyday-investors/
|
||||
- Multiple bill summaries (full text not yet accessible)
|
||||
- Lowenstein Sandler FinTech Five, May 5 2026
|
||||
|
|
@ -7,10 +7,13 @@ date: 2026-05-04
|
|||
domain: ai-alignment
|
||||
secondary_domains: [grand-strategy]
|
||||
format: synthetic-analysis
|
||||
status: unprocessed
|
||||
status: processed
|
||||
processed_by: theseus
|
||||
processed_date: 2026-05-08
|
||||
priority: medium
|
||||
tags: [Mode-5, EU-AI-Act, enforcement, governance-failure, mandatory-mechanism, August-2026, military-exclusion, Mode5-variant, B1-disconfirmation]
|
||||
intake_tier: research-task
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -7,10 +7,13 @@ date: 2026-05-06
|
|||
domain: ai-alignment
|
||||
secondary_domains: []
|
||||
format: thread
|
||||
status: unprocessed
|
||||
status: processed
|
||||
processed_by: theseus
|
||||
processed_date: 2026-05-08
|
||||
priority: medium
|
||||
tags: [eu-ai-act, omnibus, european-parliament, fixed-deadline, nudification, may13-trilogue, mode5]
|
||||
intake_tier: research-task
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -7,10 +7,13 @@ date: 2026-05-01
|
|||
domain: ai-alignment
|
||||
secondary_domains: [grand-strategy]
|
||||
format: thread
|
||||
status: unprocessed
|
||||
status: processed
|
||||
processed_by: theseus
|
||||
processed_date: 2026-05-08
|
||||
priority: high
|
||||
tags: [pentagon, classified-ai, il6-il7, alignment-tax, open-weight, reflection-ai, anthropic-exclusion, b1-confirmation]
|
||||
intake_tier: research-task
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -7,10 +7,13 @@ date: 2026-03-31
|
|||
domain: entertainment
|
||||
secondary_domains: []
|
||||
format: article
|
||||
status: unprocessed
|
||||
status: processed
|
||||
processed_by: clay
|
||||
processed_date: 2026-05-08
|
||||
priority: high
|
||||
tags: [netflix, creator-economy, platform-mediated-alignment, world-baseball-classic, community-distribution, loss-leader, 270m-views]
|
||||
intake_tier: research-task
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -7,10 +7,13 @@ date: 2026-05-01
|
|||
domain: health
|
||||
secondary_domains: []
|
||||
format: press-release
|
||||
status: unprocessed
|
||||
status: processed
|
||||
processed_by: vida
|
||||
processed_date: 2026-05-08
|
||||
priority: medium
|
||||
tags: [WeightWatchers, GLP-1, oral-semaglutide, obesity, behavioral-health, atoms-to-bits, Belief-4]
|
||||
intake_tier: research-task
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -7,10 +7,13 @@ date: 2026-01-01
|
|||
domain: health
|
||||
secondary_domains: []
|
||||
format: research-summary
|
||||
status: unprocessed
|
||||
status: processed
|
||||
processed_by: vida
|
||||
processed_date: 2026-05-08
|
||||
priority: high
|
||||
tags: [GLP-1, semaglutide, depression, MDD, psychiatric-safety, alcohol-use-disorder, behavioral-health, safety-signal]
|
||||
intake_tier: research-task
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -7,10 +7,13 @@ date: 2026-04-28
|
|||
domain: health
|
||||
secondary_domains: []
|
||||
format: news-analysis
|
||||
status: unprocessed
|
||||
status: processed
|
||||
processed_by: vida
|
||||
processed_date: 2026-05-08
|
||||
priority: medium
|
||||
tags: [GLP-1, addiction, opioid-use-disorder, nicotine, cocaine, substance-use-disorder, VTA-dopamine, reward-mechanism]
|
||||
intake_tier: research-task
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -7,10 +7,13 @@ date: 2026-05-02
|
|||
domain: internet-finance
|
||||
secondary_domains: []
|
||||
format: news-article
|
||||
status: unprocessed
|
||||
status: processed
|
||||
processed_by: rio
|
||||
processed_date: 2026-05-08
|
||||
priority: high
|
||||
tags: [Massachusetts, SJC, Kalshi, CFTC, prediction-markets, preemption, state-AGs, oral-argument, gaming, CEA]
|
||||
intake_tier: research-task
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
|
|
@ -7,10 +7,13 @@ date: 2026-05-05
|
|||
domain: internet-finance
|
||||
secondary_domains: []
|
||||
format: article
|
||||
status: unprocessed
|
||||
status: processed
|
||||
processed_by: rio
|
||||
processed_date: 2026-05-08
|
||||
priority: high
|
||||
tags: [prediction-markets, CFTC, event-contracts, prediction-market-act, NYSE, tokenization, SEC, binary-options, futarchy-regulatory]
|
||||
intake_tier: research-task
|
||||
extraction_model: "anthropic/claude-sonnet-4.5"
|
||||
---
|
||||
|
||||
## Content
|
||||
Loading…
Reference in a new issue